The U.S. is in the midst of a major push to pay for healthcare on the basis of quality over quantity, and bundled payments are regarded as an especially promising model. Medicare's Comprehensive Care for Joint Replacement model, which began in April and is mandatory for 800 hospitals in 67...
McKesson Corp. is developing an interoperability platform that leverages fast healthcare interoperability resources in an effort to move providers toward value-based payment models.
The Department of Justice has asked for additional information from drug distributor McKesson Corp. and tech firm Change Healthcare regarding the companies' proposed merger, both firms said Tuesday.
Three months after leaving Accretive Health, an embattled revenue-cycle company, Dr. Emad Rizk is now the CEO of Verscend Technologies.
Data Points for the week of Aug. 1, 2016, covered the following topics: Health information technology deals, mergers and acquisitions; providers' IT budgets; venture capital in health IT; startup accelerators for health IT.
Shareholders at McKesson's annual meeting sided with the board and management in rejecting proposals to require greater disclosure of political contributions and limit golden parachutes for senior executives in a change of ownership.
McKesson Corp. may be weighing a separation of its information technology unit as it works to contain costs and refocus on its core drug distribution business, according to the Wall Street Journal.
The rise of high-deductible health insurance is challenging providers across the country to change the way they prepare for and collect payments from people getting hit with large out-of-pocket costs for care.
McKesson Corp. announced two deals with big-box chain Wal-Mart Stores that are expected to boost the healthcare giant after recent struggles.
Fourth-quarter and full-year earnings soared at healthcare giant McKesson Corp., mostly due to the absence of previous acquisition-related charges.
An effort to develop technology to enroll a portion of the 1 million volunteers in the White House's Precision Medicine Initiative is placing a spotlight on one possible solution to interoperability and in the meantime creating unprecedented collaboration.
Hospital systems now routinely deal with an uncomfortable number of drug shortages, so they're forging direct relationships with manufacturers, and buying directly from the source when the usual channels dry up.